Strategic Partnerships Kent Imaging has recently expanded distribution and partnerships, including a collaboration with Marathon Medical Corporation and a deal with New Horizon Medical Solutions LLC. Opportunities exist to target federal healthcare distributors and SDVOSB networks, emphasizing expanded reach in wound care imaging and real-time bioburden detection.

Product Expansion With SnapshotNIR and SnapshotGLO, the company is broadening its portfolio into tissue oxygenation imaging and bacterial autofluorescence detection. This opens cross-selling opportunities across wound care, vascular, and surgical departments, as well as potential integration with major EHR systems like Epic.

Clinical Validation Clinical evidence supports SnapshotNIR's decision-making capabilities, and SnapshotGLO provides real-time bioburden insights. Emphasize case studies and targeted demonstrations to hospitals seeking objective data to justify adoption and reimbursement discussions.

Regulatory Momentum Recent regulatory clearances and CE marking for SnapshotNIR and SnapshotGLO signal readiness for broader markets. Sales efforts should focus on North American and European facilities looking to upgrade wound care imaging capabilities and reduce complications.

Digital Ecosystem Kent’s tech stack and software updates including Epic integration position the company for enterprise-scale deployment. Target large health systems and integrated networks with a need for interoperable imaging data that ties into existing clinical workflows.